GMP-Compliant Human Fetal Skin Fibroblasts for Wound Healing

Authors:
  • PGParisa Goodarzi
    Parisa Goodarzi
  • KFKhadijeh Falahzadeh
    Khadijeh Falahzadeh
  • HAHamidreza Aghayan
    Hamidreza Aghayan
  • FJFereshteh Mohamadi Jahani
    Fereshteh Mohamadi Jahani
  • MPMoloud Payab
    Moloud Payab
  • KGKambiz Gilany
    Kambiz Gilany
  • BLBagher Larijani
    Bagher Larijani
  • ABAkram Tayanloo Beik
    Akram Tayanloo Beik
  • HAHossein Adibi
    Hossein Adibi
Open Access
Publisher website
Google Scholar
Abstract
Background: Among different kinds of cells involved in the wound healing process, fibroblasts play a pivotal role in the proliferation phase of this procedure wherein they induce the production of local growth factors and cytokines. Fetal fibroblasts with low immunogenic property and different wound healing process could be considered as a suitable alternative to neonatal foreskin cell based products in regenerative medicine and cell therapy. Cell therapy is an almost newly introduced method in the medical field and is also a challenging issue, which should assure the safety of the final product and the absence of viral or bacterial contamination with minimal immunogenic response. Therefore, based on current GMP (cGMP) principles, it is a matter of great importance to monitor raw materials’ quality and the conformity of all production procedures including cell culture, collection, and cryopreservation with validated standard operating procedures (SOPs). In the current study, we demonstrated the GMP-compatible and clinical-grade fetal fibroblast cells banking to be used for clinical applications. Methods: All steps of isolation and culturing and cryopreservation of fetal fibroblast cells were performed under the sterile condition according to cGMP guidelines in the clean room. During the cell culture procedures, bacteriological investigation was performed in order to identify the probable contamination of the samples. Results: Isolated fetal dermal fibroblasts were harvested and stored at early passages. The viability of fibroblasts was ≥ 98%, indicating successful establishment of fibroblast banking. Flow cytometry analysis has revealed the high purity of isolated and cultured fibroblastic population Karyotyping of fibroblasts at the 10th subculture shows a normal diploid male pattern. Conclusions: The manufactured cells, according to the highest level of safety are considered as the most appropriate treatment option for cellular therapy. Based-on the current evidence, clinical-grade fetal fibroblasts throw new light on efficient and prompt healing of acute and chronic wounds of any etiology. Keywords: Fibroblasts; GMP; Wound healing

This publication has 38 references indexed in Scilit: